Nadia Di Muzio Selected Research

Nadia Di Muzio Research Topics

Disease

29	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 08/2007
20	Neoplasms (Cancer) 04/2022 - 01/2008
7	Head and Neck Neoplasms (Head and Neck Cancer) 09/2015 - 03/2006
5	Neoplasm Metastasis (Metastasis) 04/2020 - 11/2017
5	Margins of Excision 07/2012 - 11/2009
4	Pancreatic Neoplasms (Pancreatic Cancer) 10/2019 - 07/2012
4	Adenocarcinoma 12/2013 - 06/2008
3	Carcinoma (Carcinomatosis) 01/2012 - 07/2008
2	COVID-19 04/2022 - 11/2020
2	Disease Progression 01/2022 - 04/2020
2	Glioma (Gliomas) 12/2021 - 12/2017
2	Breast Neoplasms (Breast Cancer) 09/2019 - 06/2019
2	Rectal Neoplasms (Rectal Cancer) 11/2018 - 09/2013
2	Lymphatic Metastasis 01/2018 - 05/2011
2	Extranodal Extension 07/2012 - 01/2011
2	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 10/2008 - 09/2007
1	Infections 04/2022
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2021
1	Pelvic Neoplasms 01/2020
1	Anus Neoplasms (Anal Cancer) 01/2020
1	Urinary Incontinence 01/2020
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 10/2019
1	Malignant Mesothelioma 01/2019
1	Pathologic Complete Response 11/2018
1	Cognitive Dysfunction 01/2018
1	Hypoxia (Hypoxemia) 12/2017
1	AIDS-Related Complex (ARC) 12/2014
1	Residual Neoplasm 09/2013
1	Neuroblastoma 12/2012
1	Hypertension (High Blood Pressure) 01/2012
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 05/2010
1	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 05/2010
1	Lymphoma (Lymphomas) 05/2010
1	Rare Diseases (Rare Disease) 03/2010
1	Plasma Cell Granuloma 03/2010
1	Mucinous Adenocarcinoma (Mucinous Carcinoma) 11/2009
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2009
1	Inflammation (Inflammations) 03/2009
1	Neurosarcoidosis 03/2008
1	Adenoid Cystic Carcinoma (Cylindroma) 01/2008
1	Hemorrhage 08/2007
1	Hematuria 12/2003

Drug/Important Bio-Agent (IBA)

4	Prostate-Specific Antigen (Semenogelase)IBA 04/2020 - 02/2010
3	Choline (Choline Chloride)IBA 09/2010 - 02/2010
2	AndrogensIBA 04/2020 - 01/2018
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2018 - 03/2009
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2022
1	Hormones (Hormone)IBA 01/2022
1	Androgen Receptors (Androgen Receptor)IBA 01/2022
1	AntigensIBA 10/2019
1	Macromolecular SubstancesIBA 01/2018
1	abirateroneIBA 01/2018
1	SphingolipidsIBA 01/2018
1	fluoroazomycin arabinosideIBA 12/2017
1	Capecitabine (Xeloda)FDA Link 12/2013
1	Biological ProductsIBA 12/2013
1	GlucosidasesIBA 12/2012
1	GalactosidasesIBA 12/2012
1	Neuraminidase (Sialidase)IBA 12/2012
1	Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA 12/2012
1	Epirubicin (Ellence)FDA LinkGeneric 07/2012
1	Cisplatin (Platino)FDA LinkGeneric 07/2012
1	Fluorouracil (Carac)FDA LinkGeneric 07/2012
1	Gemcitabine FDA Link 07/2012
1	Estramustine FDA Link 07/2010
1	PlasticsIBA 03/2010
1	SteroidsIBA 03/2010
1	Glucose (Dextrose)FDA LinkGeneric 03/2009

Therapy/Procedure

42	Radiotherapy 04/2022 - 12/2003
19	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2021 - 03/2006
13	Prostatectomy (Retropubic Prostatectomy) 01/2021 - 08/2007
11	Therapeutics 04/2022 - 07/2010
4	Drug Therapy (Chemotherapy) 09/2015 - 05/2010
4	Adjuvant Radiotherapy 06/2013 - 07/2008
4	Proton Therapy 05/2013 - 10/2008
3	Chemoradiotherapy 10/2019 - 09/2013
3	Image-Guided Radiotherapy 01/2017 - 11/2009
1	Personal Protective Equipment 04/2022
1	Castration 01/2022
1	Induction Chemotherapy 12/2013
1	Combination Drug Therapy (Combination Chemotherapy) 07/2012
1	Lymph Node Excision (Lymph Node Dissection) 11/2009